The anti-CSF1R Cabiralizu Biosimilar (HDBS0054) is a cutting-edge monoclonal antibody designed for researchers studying CSF1R, a cell surface receptor involved in regulating immune function and inflammation. This biosimilar, produced through a specialized process, offers exceptional specificity and sensitivity for detecting and analyzing CSF1R protein in various cell types.CSF1R, also known as colony-stimulating factor-1 receptor, plays a vital role in immune responses and the development of certain immune cells. Dysregulation of CSF1R signaling has been linked to various diseases, including cancer and autoimmune disorders.
The anti-CSF1R Cabiralizu Biosimilar provides researchers with a valuable tool for investigating the role of CSF1R in these conditions, ultimately aiding in the development of novel therapies targeting this receptor.With its high reactivity and proven performance in assays such as Western blotting, the anti-CSF1R Cabiralizu Biosimilar is a reliable choice for immunology and cancer research. By providing insights into the molecular mechanisms underlying CSF1R function, this biosimilar facilitates a better understanding of immune regulation and offers potential new avenues for therapeutic intervention.
Product Name:
Cabiralizumab (Anti-CSF1R) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0054
Target:
CSF1R
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
FPA-008,FPA008
Description:
Anti-CSF1R(cabiralizumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
